The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.
Category: Coronavirus Omicron Variant
-
Covid Vaccines May Roll Out Within Days
The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.
-
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.
-
F.D.A. Outlines a Plan for Annual Covid Boosters
The New York Times – Business:In advance of a scientific meeting on Thursday, officials proposed offering new shots to Americans each fall, a strategy long employed against the flu.
-
How Bad Is China’s Covid Outbreak? It’s a Scientific Guessing Game.
The New York Times – Business:In the absence of credible information from the Chinese government, researchers around the world are looking for any clues to determine the size and severity of the surge.
-
China Eases ‘Zero Covid’ Restrictions in Victory for Protesters
The New York Times – Business:Beijing’s costly policy of lockdowns has pummeled the world’s second-largest economy and set off mass public protests that were a rare challenge to China’s leader, Xi Jinping.
-
Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
The New York Times – Business:The shots may help older, pregnant and immunocompromised Americans dodge serious illness or death. But the doses are not likely to prevent infections in any group, recent studies suggest.